<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00582829</url>
  </required_header>
  <id_info>
    <org_study_id>03-043</org_study_id>
    <nct_id>NCT00582829</nct_id>
  </id_info>
  <brief_title>Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients</brief_title>
  <official_title>Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fox Chase Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lombardi Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Micromass Communications, Cary, NC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Christiana Care Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pinnacle Health Regional Cancer Center, Harrisburg, PA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Mary Regional Cancer Center, Langhorne, PA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>South Jersey Regional Cancer Center, Bridgton, New Jersey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hunterdon Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northeast Regional Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virtua Memorial Hospital and Virtua West</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jersey Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rutgers Cancer Institute of New Jersey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Main Line Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HematologyOncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Associates of Central New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <brief_summary>
    <textblock>
      This proposed study will use previous study results to guide the development and evaluation
      of interventions to improve CRC screening acceptance. The proposed study will evaluate the
      impact of three interventions to promote CRC screening among siblings in this increased-risk
      group, who are not currently compliant with CRC screening guidelines: 1) a generic print
      intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored
      telephone counseling intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      First-degree relatives of individuals with CRC are at increased-risk of developing colorectal
      cancer (CRC). For these increased-risk individuals current guidelines recommend initiating
      CRC screening a decade earlier than for those at average-risk for CRC; thus, starting at age
      40, or 10 years younger than the age at which the affected relative was diagnosed with CRC.
      In our prior study of 504 at-risk siblings of patients with a history of CRC, diagnosed at
      age less than 56, we found that approximately 44% of these siblings were not compliant with
      CRC screening guidelines. Guided by the Transtheoretical, Health Belief and Dual Process
      models, our prior study identified key attitudinal and non-attitudinal predictors of
      screening behaviors and intentions.

      This proposed study will use these results to guide the development and evaluation of
      interventions to improve CRC screening acceptance. The proposed study will evaluate the
      impact of three interventions to promote CRC screening among siblings in this increased-risk
      group, who are not currently compliant with CRC screening guidelines: 1) a generic print
      intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored
      telephone counseling intervention.

      Siblings in the generic print condition will receive a pamphlet about colorectal cancer
      screening published by the Center for Disease Control. Siblings in the tailored print and
      telephone counseling conditions will receive messages tailored specifically to their
      responses on targeted attitudinal and non-attitudinal measures. Five hundred twenty four
      siblings meeting eligibility criteria will be randomly assigned to one of the three
      conditions after a baseline interview assessing CRC screening behaviors and attitudes, and it
      is anticipated that 427 siblings will complete the study. For siblings in the tailored
      conditions, baseline information will be utilized to design the tailored messages. After
      receiving the intervention information, participants will be interviewed again six months
      later regarding CRC screening behaviors and attitudes to assess the impact of the
      intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2003</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Phone follow-up interview. Participants will be contacted by study assistant and the survey administered.</measure>
    <time_frame>6 months after baseling</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">213</enrollment>
  <condition>Colorectal</condition>
  <condition>Cancer</condition>
  <condition>Screening</condition>
  <condition>Intervention</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Generic Print Intervention: The generic print intervention will consist of the pamphlet, &quot;Colorectal Cancer Screening Saves Lives&quot; published by the Center for Disease Control that will be mailed to the participant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Tailored Print Intervention: The tailored print intervention will consist of a cover letter detailing the participant's stage of readiness along with a color pamphlet with information personally tailored for the individual participant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Tailored print plus tailored phone intervention: The tailored print plus tailored telephone intervention will consist of a phone counseling session and the tailored print information described above. The tailored print material will serve as a guide during the telephone counseling contact and a reinforcement of the information.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Generic Print Intervention</intervention_name>
    <description>Generic Print Intervention: The generic print intervention will consist of the pamphlet, &quot;Colorectal Cancer Screening Saves Lives&quot; published by the Center for Disease Control that will be mailed to the participant.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tailored Print Intervention</intervention_name>
    <description>Tailored Print Intervention: The tailored print intervention will consist of a cover letter detailing the participant's stage of readiness along with a color pamphlet with information personally tailored for the individual participant.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tailored print plus tailored phone intervention</intervention_name>
    <description>Tailored print plus tailored phone intervention: The tailored print plus tailored telephone intervention will consist of a phone counseling session and the tailored print information described above. The tailored print material will serve as a guide during the telephone counseling contact and a reinforcement of the information.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  How old is the participant? (â‰¥ 18 years)

          -  Is the participant either:

          -  currently age 40 or above (YES) OR

          -  within 10 years of the age at which the patient/proband was initially diagnosed with
             CRC (whichever is the younger age) (YES)

          -  Is the participant a full or half biological sibling of the patient/proband? (YES)

        Exclusion Criteria:

          -  Is the participant currently not compliant with standard CRC screening guidelines?
             (NO)

          -  Is the participant English speaking? (YES)

          -  Does the participant have a primary language other than English? (NO)

          -  Does the participant have a history of Inflammatory Bowel Disease? (NO)

          -  Does the participant have a history of colorectal cancer of colorectal polyp? (NO)

          -  Does the participant have a history of hereditary colorectal cancer syndrome?
             (Familial Adenomatous Polyposis or Hereditary Nonpolyposis Colorectal Cancer) (NO)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnold Markowitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2007</study_first_posted>
  <last_update_submitted>November 6, 2008</last_update_submitted>
  <last_update_submitted_qc>November 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Arnold Markowitz</name_title>
    <organization>Memorial Sloan Kettering Cancer Center</organization>
  </responsible_party>
  <keyword>Colorectal</keyword>
  <keyword>Cancer</keyword>
  <keyword>Screening</keyword>
  <keyword>Intervention</keyword>
  <keyword>Family</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

